Conformation specific antibodies

Details for Australian Patent Application No. 2005215024 (hide)

Owner The CBR Institute for Biomedical Research, Inc. Dyax Corp.

Inventors Cohen, Edward H.; Rondon, Isaac J.

Agent Cullens

Pub. Number AU-B-2005215024

PCT Pub. Number WO2005/079515

Priority 60/546,354 19.02.04 US

Filing date 22 February 2005

Wipo publication date 1 September 2005

Acceptance publication date 21 July 2011

International Classifications

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/46 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

Event Publications

21 September 2006 PCT application entered the National Phase

  PCT publication WO2005/079515 Priority application(s): WO2005/079515

21 July 2011 Application Accepted

  Published as AU-B-2005215024

17 November 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005215033-Method and apparatus for converting human power to electrical power

2005215020-System immune activation method using non CpG nucleic acids